- Report
- April 2024
- 84 Pages
Global
From €2282EUR$2,400USD£1,917GBP
- Report
- January 2025
- 120 Pages
Global
From €5656EUR$5,950USD£4,752GBP
- Report
- June 2021
- 265 Pages
Global
From €4562EUR$4,799USD£3,833GBP
- Report
- April 2023
- 112 Pages
Global
From €4516EUR$4,750USD£3,794GBP
- Report
- December 2023
- 91 Pages
Global
From €3500EUR$3,944USD£3,043GBP
- Report
- June 2023
- 74 Pages
Global
From €3500EUR$3,944USD£3,043GBP
- Report
- January 2021
- 262 Pages
Global
From €3529EUR$3,712USD£2,965GBP
- Book
- October 2020
- 640 Pages
- Book
- January 2018
- 272 Pages
- Book
- September 2010
- 418 Pages
- Book
- February 2010
- 314 Pages
- Book
- November 2008
- 288 Pages
- Book
- March 2022
- 336 Pages
- Book
- March 2020
- 160 Pages
- Book
- February 2019
- 464 Pages
- Book
- February 2018
- 880 Pages

The Cell Cycle market within the context of Genomics is a rapidly growing field of research and development. It is focused on understanding the molecular mechanisms that control the progression of cells through the cell cycle. This includes the regulation of cell division, DNA replication, and cell death. It is an important area of research for understanding the development and progression of diseases, as well as for developing new treatments and therapies.
The Cell Cycle market is driven by advances in sequencing technologies, which have enabled researchers to better understand the molecular mechanisms that control the cell cycle. This has led to the development of new tools and techniques for studying the cell cycle, such as single-cell sequencing and high-throughput sequencing.
Companies in the Cell Cycle market include Illumina, Thermo Fisher Scientific, Agilent Technologies, Bio-Rad Laboratories, and PerkinElmer. These companies provide a range of products and services related to the study of the cell cycle, including sequencing technologies, reagents, and software. Show Less Read more